BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35445915)

  • 1. An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model.
    Treadwell MJ; Mushiana S; Badawy SM; Preiss L; King AA; Kroner B; Chen Y; Glassberg J; Gordeuk V; Shah N; Snyder A; Wun T;
    Qual Life Res; 2022 Sep; 31(9):2681-2694. PubMed ID: 35445915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes in sickle cell disease and association with clinical and psychosocial factors: Report from the sickle cell disease implementation consortium.
    Knisely MR; Pugh N; Kroner B; Masese R; Gordeuk V; King AA; Smith SM; Gurney JG; Adams R; Wun T; Snyder A; Glassberg J; Shah N; Treadwell M;
    Am J Hematol; 2020 Sep; 95(9):1066-1074. PubMed ID: 32449965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠.
    Keller S; Yang M; Treadwell MJ; Hassell KL
    Health Qual Life Outcomes; 2017 Jun; 15(1):117. PubMed ID: 28577358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks.
    Keller SD; Yang M; Treadwell MJ; Werner EM; Hassell KL
    Health Qual Life Outcomes; 2014 Aug; 12():125. PubMed ID: 25146160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.
    Masese RV; Bulgin D; Knisely MR; Preiss L; Stevenson E; Hankins JS; Treadwell MJ; King AA; Gordeuk VR; Kanter J; Gibson R; Glassberg JA; Tanabe P; Shah N;
    PLoS One; 2021; 16(10):e0258638. PubMed ID: 34714833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium.
    Dampier C; LeBeau P; Rhee S; Lieff S; Kesler K; Ballas S; Rogers Z; Wang W;
    Am J Hematol; 2011 Feb; 86(2):203-5. PubMed ID: 21264908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.
    Badawy SM; Thompson AA; Lai JS; Penedo FJ; Rychlik K; Liem RI
    Health Qual Life Outcomes; 2017 Jul; 15(1):136. PubMed ID: 28679417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease.
    Harris KM; Preiss L; Varughese T; Bauer A; Calhoun CL; Treadwell M; Masese R; Hankins JS; Hussain FA; Glassberg J; Melvin CL; Gibson R; King AA;
    JAMA Netw Open; 2023 May; 6(5):e2314070. PubMed ID: 37200033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care.
    Kanter J; Gibson R; Lawrence RH; Smeltzer MP; Pugh NL; Glassberg J; Masese RV; King AA; Calhoun C; Hankins JS; Treadwell M
    JAMA Netw Open; 2020 May; 3(5):e206016. PubMed ID: 32469413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research.
    Treadwell MJ; Hassell K; Levine R; Keller S
    Clin J Pain; 2014 Oct; 30(10):902-14. PubMed ID: 24300219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease.
    Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L
    Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specifying sickle cell disease interventions: a study protocol of the Sickle Cell Disease Implementation Consortium (SCDIC).
    Baumann AA; Belle SH; James A; King AA;
    BMC Health Serv Res; 2018 Jun; 18(1):500. PubMed ID: 29945631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease.
    Mucalo L; Field JJ; Highland J; Khan H; Hankins JS; Singh A; Brandow AM
    Blood Adv; 2023 Jul; 7(14):3658-3665. PubMed ID: 37058480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.
    Dampier C; Barry V; Gross HE; Lui Y; Thornburg CD; DeWalt DA; Reeve BB
    Pediatr Blood Cancer; 2016 Jun; 63(6):1031-7. PubMed ID: 26895143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health related quality of life in sickle cell patients: the PiSCES project.
    McClish DK; Penberthy LT; Bovbjerg VE; Roberts JD; Aisiku IP; Levenson JL; Roseff SD; Smith WR
    Health Qual Life Outcomes; 2005 Aug; 3():50. PubMed ID: 16129027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.
    Badawy SM; Thompson AA; Penedo FJ; Lai JS; Rychlik K; Liem RI
    Eur J Haematol; 2017 Jun; 98(6):608-614. PubMed ID: 28306171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily functioning and quality of life in children with sickle cell disease pain: relationship with family and neighborhood socioeconomic distress.
    Palermo TM; Riley CA; Mitchell BA
    J Pain; 2008 Sep; 9(9):833-40. PubMed ID: 18550443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotion regulation, pain interference and affective symptoms in children and adolescents with sickle cell disease.
    Miller M; Balsamo L; Pashankar F; Bailey CS
    J Affect Disord; 2021 Mar; 282():829-835. PubMed ID: 33601724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic symptom burden in adults with sickle cell disease predicts pain, depression, anxiety, health care utilization, and quality of life: the PiSCES project.
    Sogutlu A; Levenson JL; McClish DK; Rosef SD; Smith WR
    Psychosomatics; 2011; 52(3):272-9. PubMed ID: 21565599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY).
    Osunkwo I; Andemariam B; Minniti CP; Inusa BPD; El Rassi F; Francis-Gibson B; Nero A; Trimnell C; Abboud MR; Arlet JB; Colombatti R; de Montalembert M; Jain S; Jastaniah W; Nur E; Pita M; DeBonnett L; Ramscar N; Bailey T; Rajkovic-Hooley O; James J
    Am J Hematol; 2021 Apr; 96(4):404-417. PubMed ID: 33264445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.